NUCRYST Pharmaceuticals Corp. (USA) (NASDAQ:NCST)

CAPS Rating: No stars

The Company develops, manufactures and commercializes innovative medical products that fight infection and inflammation.

Results 1 - 3 of 3

Recs

stevesliva (94.71) Submitted: 11/9/2006 6:52:40 PM : Outperform

Start Price: $1.44 NCST Score: +21.78

Oversold.

Recs

jwolfe5 (< 20) Submitted: 11/8/2006 5:50:17 PM : Outperform

Start Price: $1.43 NCST Score: +22.64

NCST has bottomed out and is ready for several months of positive returns.

Recs

Braema (< 20) Submitted: 8/23/2006 5:50:18 PM : Outperform

Start Price: $3.21 NCST Score: -53.57

Small cap medical device company with a very good product.

Results 1 - 3 of 3

Featured Broker Partners

Sponsored Links